Double-Blind Multicenter Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19

STATUS

Recruiting
participants needed

140
sponsor

Pluristem Ltd.

Send

Updated on 19 February 2024

See if I qualify

respiratory distress

covid-19

SARS

acute respiratory distress

acute respiratory syndrome (sars)

Summary

This clinical trial will examine if a new treatment of Mesenchymal Stems Cells (called PLX-PAD) can help patients intubated and mechanically ventilated due to COVID-19 to recover more quickly with less complications.

Details

Condition	ADULT RESPIRATORY DISTRESS SYNDROME, COVID
Age	40years - 80years
Treatment	Placebo, PLX-PAD
Clinical Study Identifier	NCT04389450
Sponsor	Pluristem Ltd.
Last Modified on	19 February 2024

How understandable was the trial content above?

Hard to understand

Easy to understand

Eligibility		Yes	No	Not Sure
Inclusion Criteria
	Willing and able to provide written informed consent, or with a legal representative who can provide informed consent
	Male or non-pregnant female adult 40-80 years of age at time of enrollment
	Laboratory-confirmed SARS-CoV-2 infection as determined by PCR, in any specimen up to 21 days prior to randomization
	Meets definition of ARDS according to Berlin criteria
Exclusion Criteria
	Body weight under 55 kg (121 lbs)
	Serum creatinine level of over 1.5 mg/dL at time of randomization
	Total Bilirubin 2 mg/dL at time of randomization
	Known allergy to any of the following: dimethyl sulfoxide (DMSO), human serum albumin, bovine serum albumin
	Stroke or acute myocardial infarction/unstable angina within 3 months prior to randomization
	Chronic Obstructive Pulmonary disease GOLD stage above II

How to participate?

Step 1 Connect with a study center

Select a site
Send a message

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Primary Contact

I am at least 18 years old.

By sending a message, I agree to share my information with the study team for the selected site and consent to receive emails and text messages for trial updates, notifications, and related communication. TrialX values your privacy; your information will be handled in accordance with our Privacy Policy

Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

respiratory distress

covid-19

SARS

acute respiratory distress

acute respiratory syndrome (sars)

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Study Definition

Wikipedia

Double-Blind Multicenter Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19